Revenue (Quarterly)

Revenue: The sum of all revenue fields included for a company's operating activities.

Biocorrx Inc. (BICX) had Revenue of $-0.15M for the most recently reported fiscal quarter, ending 2025-12-31.

Quarterly Annual

Figures for fiscal quarter ending 2025-12-31

Income Statement Financials
Revenue	$-0.15M
Net Income	$0.55M
Cost of Goods Sold	$-0.34M
Gross Profit	$0.19M
Operating Expenses	$0.38M
Operating Income	$-0.53M
Non-Operating Income/Expense	$0.06M
Pre-Tax Income	$-0.47M
Normalized Pre-Tax Income	$-0.47M
Income after Taxes	$-0.47M
Income from Continuous Operations	$-0.47M
Consolidated Net Income/Loss	$-0.47M
Normalized Income after Taxes	$-0.47M
EBIT	$-0.53M
EBITDA	$-0.53M
Weighted-Average Shares Outstanding (Basic)	18.49M
Weighted-Average Shares Outstanding (Diluted)	18.49M
Earnings per Share (EPS) (Basic)	$0.05
Earnings per Share (EPS) (Diluted)	$0.05
Balance Sheet Financials
Current Assets	$0.81M
Property, Plant, and Equipment	$0.00M
Long-Term Assets	$1.33M
Total Assets	$2.15M
Current Liabilities	$8.31M
Long-Term Debt	$4.85M
Long-Term Liabilities	$5.37M
Total Liabilities	$13.67M
Common Equity	$-11.55M
Tangible Shareholders Equity	$-12.65M
Shareholders Equity	$-11.53M
Common Shares Outstanding	24.49M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$-2.30M
Cash Flow from Investing Activities	--
Cash Flow from Financial Activities	$2.35M
Beginning Cash	$0.09M
End Cash	$0.14M
Increase/Decrease in Cash	$0.05M
Stock-Based Compensation	$0.59M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	0.10
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	-0.73
Debt to Equity Ratio	-0.59
Gross Margin	-212.28%
Operating Margin	353.49%
EBIT Margin	353.49%
EBITDA Margin	--
Pre-Tax Profit Margin	311.83%
Profit Margin	-365.65%
Free Cash Flow	$-2.30M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	-0.07
Inventory Turnover	-2.35
Receiveable Turnover	-0.49
Days Sales in Receivables	-181.94
Return on Equity	4.08%
Return on Tangible Equity	3.72%
Return on Assets	-21.95%
Return on Investments	7.06%
Book Value Per Share	$-0.47
Free Cash Flow per Share	$-0.12
Operating Cash Flow per Share	$-0.12

Data from Zacks Investment Research, Inc.